drugset

drugset / Trial / NCT00282997

A Safety Study Of Pregabalin In Fibromyalgia

NCT00282997 ↗

Phase 3 Completed 500 enrolled Viatris Inc.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the safety of pregabalin in patients with fibromyalgia.

Timeline

Start: 2006-02
Primary completion: —
Completion: 2006-10

Publications

Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G, Petersel D. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia. Clin Ther. 2012 May;34(5):1092-102. doi: 10.1016/j.clinthera.2012.03.003. Epub 2012 Apr 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	75 mg	—
Subject	Pregabalin	Small molecule	300 mg	—

Indications